Recombinant viral vectors: Cancer vaccines
- 16 August 2006
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 58 (8), 931-947
- https://doi.org/10.1016/j.addr.2006.05.005
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Induces Immune Responses which Correlate with Disease Control: A Phase I/II TrialClinical Cancer Research, 2006
- Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapyMelanoma Research, 2006
- Therapeutic Cancer Vaccines: At Midway Between Immunology and PharmacologyCurrent Cancer Drug Targets, 2005
- Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trialsExpert Review of Vaccines, 2005
- The immunology of colorectal cancerSurgical Oncology, 2004
- Mechanism of Action of Anti-Her2 Monoclonal Antibodies: Scientific Update on Trastuzumab and 2c4Published by Springer Nature ,2003
- Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative GroupThe Journal of Pathology, 2000
- Comparative Analysis of the In Vivo Expression of Tyrosinase, MART-1/Melan-A, and gp100 in Metastatic Melanoma Lesions: Implications for ImmunotherapyJournal of Immunotherapy, 1998
- The Multi-epitope Approach for Immunotherapy for Cancer: Identification of Several CTL Epitopes from Various Tumor-Associated Antigens Expressed on Solid Epithelial TumorsHuman Immunology, 1998
- Vaccinia virus: a selectable eukaryotic cloning and expression vector.Proceedings of the National Academy of Sciences, 1982